213 related articles for article (PubMed ID: 17243968)
21. Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage.
Gambichler T; Tigges C; Dith A; Skrygan M; Scola N; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jan; 164(1):110-5. PubMed ID: 20973771
[TBL] [Abstract][Full Text] [Related]
22. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
Daulat S; Detweiler JG; Pandya AG
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
[No Abstract] [Full Text] [Related]
23. Palmoplantar pustular psoriasis unresponsive to the interleukin-1β antagonist canakinumab.
Mansouri B; Kivelevitch D; Campa M; Menter A
Clin Exp Dermatol; 2016 Apr; 41(3):324-6. PubMed ID: 26344848
[No Abstract] [Full Text] [Related]
24. Etanercept therapy in two patients with psoriasis and concomitant hepatitis C.
De Simone C; Paradisi A; Capizzi R; Carbone A; Siciliano M; Amerio PL
J Am Acad Dermatol; 2006 Jun; 54(6):1102-4. PubMed ID: 16713482
[No Abstract] [Full Text] [Related]
25. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
Yamauchi PS; Lowe NJ
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
[No Abstract] [Full Text] [Related]
26. Pilot study using teledermatology to manage high-need patients with psoriasis.
Frühauf J; Schwantzer G; Ambros-Rudolph CM; Weger W; Ahlgrimm-Siess V; Salmhofer W; Hofmann-Wellenhof R
Arch Dermatol; 2010 Feb; 146(2):200-1. PubMed ID: 20157037
[No Abstract] [Full Text] [Related]
27. The treatment of psoriasis with etanercept.
Strober BE
Semin Cutan Med Surg; 2005 Mar; 24(1):28-36. PubMed ID: 15900796
[TBL] [Abstract][Full Text] [Related]
28. Two years of experience with etanercept in recalcitrant psoriasis.
Ahmad K; Rogers S
Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
[TBL] [Abstract][Full Text] [Related]
29. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
Thielen AM; Barde C; Marazza G; Saurat JH
Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
[TBL] [Abstract][Full Text] [Related]
30. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
Safa G; Loppin M; Bousser AM; Barbarot S
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
[No Abstract] [Full Text] [Related]
31. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
Yamauchi PS; Lowe NJ; Gindi V
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
[No Abstract] [Full Text] [Related]
32. Treatment of pustulosis palmaris et plantaris with oral doses of colchicine.
Takigawa M; Miyachi Y; Uehara M; Tagami H
Arch Dermatol; 1982 Jul; 118(7):458-60. PubMed ID: 7092269
[TBL] [Abstract][Full Text] [Related]
33. Treatment of pustulosis palmaris et plantaris with colchicine. A double-blind cross-over trial.
Thestrup-Pedersen K; Reymann F
Acta Derm Venereol; 1984; 64(1):76-8. PubMed ID: 6203289
[TBL] [Abstract][Full Text] [Related]
34. Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
Piccolo D; Di Cesare A; Fargnoli MC; Paoloni M; Vecchiotti S; Peris K
Eur J Dermatol; 2008; 18(4):459-60. PubMed ID: 18573723
[No Abstract] [Full Text] [Related]
35. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
[No Abstract] [Full Text] [Related]
36. Etanercept for toxic epidermal necrolysis.
Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
[No Abstract] [Full Text] [Related]
37. Pustulosis palmaris et plantaris treated with hydroxyurea.
Hattel T; Sondergaard J
Acta Derm Venereol; 1974; 54(2):152-4. PubMed ID: 4133022
[No Abstract] [Full Text] [Related]
38. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
39. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
Collazo MH; González JR; Torres EA
P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
[TBL] [Abstract][Full Text] [Related]
40. Etanercept therapy of psoriatic arthritis in a patient with liver cirrhosis.
Lehnen M; Franckson T; Korber A; Grabbe S; Dissemond J
Acta Derm Venereol; 2005; 85(4):351-2. PubMed ID: 16191861
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
